期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RANKL/RANK/OPG系统造成人工关节假体无菌性松动的机制 被引量：1

The RANKL/RANK/OPG System and Aseptic Loosening of Artificial Joint
下载PDF
导出
摘要 人工关节假体无菌性松动是影响关节置换术长期疗效的重要因素。许多研究表明,无菌性松动与RANKL/RANK/OPG系统的关系密切。该系统是在破骨细胞分化、激活和凋亡过程中的一个重要信号调节系统,将骨代谢、免疫系统和内分泌系统紧密地联系起来。研究发现,体内多种激素和细胞因子等均直接或间接地调节该系统的表达,调控RANKL、OPG二者之间的平衡,从而介导破骨细胞的分化和功能而达到影响骨代谢的作用。该文就近年RANKL/RANK/OPG系统与人工关节无菌性松动机制的研究进展作一综述。 Aseptic loosening of artificial joint is the important factor affecting the in-service life of prosthetic replacement. Many researches indicate there is a close correlation between the RANKL/RANK/OPG system and aseptic loosening. This system regulates osteoclast formation, activation and survival, it makes bone metabolism, immune system and endocrine system connect tightly. Researches discover many hormones and cytokines can regulate the expression of this system directly or indirectly, to mediate the differentiation and function of osteoclast, and finally to influence bone metabolism. This article reviews studies about the role of the RANKL/RANK/OPG system in aseptic loosening.
作者 陈昱铭 熊奡 曾晖
机构地区 汕头大学医学院 北京大学深圳医院骨关节科
出处 《医学综述》 2008年第21期3205-3208,共4页 Medical Recapitulate
基金 深圳市科技计划项目(200702042) 教育部留学回国人员科研启动基金(2006-331号)
关键词 细胞核因子κB受体活化因子配基 细胞核因子κB受体活化因子 骨保护素 人工关节 无菌性松动 Receptor activator of nuclear factor-kappa B ligand Receptor activator of nuclear factorkappa B Osteoprotegerin Artificial joint Aseptic loosening
分类号 R687.42 [医药卫生—骨科学]
  • 相关文献

参考文献28

  • 1Saleh K J, Thongtrangan I, Schwarz EM. Osteolysis: medical and surgical approaches [ J ]. Clin Orthop Relat Res, 2004 ( 427 ) : 138-147.
  • 2Koseki H, Matsumoto T, Ito S, et al. Analysis of polyethylene particles isolated from periprosthetic tissue of loosened hip arthroplasty and comparison with radiographic appearance [ J ]. J Orthop Sci, 2005,10 (3) :284-290.
  • 3Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption,density, geometry and strength [ J ]. Curr Opin Pharmacol, 2005,5(6) :618-625.
  • 4Kobayashi N, Kadono Y, Naito A ,et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis [J]. EMBO J,2001,20(6) :1271-1280.
  • 5Gori F, Hofbauer LC, Dunstan CR, et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage ceils is developmentally regulated [ J ]. Endocrinology,2000,141 ( 12 ) :4768 -4776.
  • 6Hotbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology[ J]. J Mol Med,2001,79(5/6) :243-253.
  • 7张银光,王岩.人工关节置换术后的无菌性松动——多因素共同作用的结果[J].医学综述,2008,14(4):590-593. 被引量：6
  • 8Ramage SC, Urban NH,Jiranek WA. Expression of RANKL in osteolytic membranes : association with fibroblastic cell markers [ J ]. J Bone Joint Surg Am,2007,89(4) :841-848.
  • 9Veigl D, Niederlova J, Krystufkova O. Periprosthetie osteolysis and its association with RANKL expression [ J ]. Physiol Res, 2007,56 (4) :455-462.
  • 10Haynes DR, Crotti TN, Potter AE, et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis[ J]. J Bone Joint Surg Br,2001,83 (6) :902-911.

二级参考文献21

  • 1Hirakawa K, Jacobs JJ, Urban R, et al. Mechanisms of failure of total hip replacements: lessons learned from retrieval studies[J]. Clin Orthop Relat Res,2004, (420) : 10-17.
  • 2Dowd JE, Sychterz CJ, Young AM, et al. Characterization of long-term femoral-head-penetration rates. Association with and prediction of osteolysis[J] .J Bone Joint Surg Am,2000,82(8) : 1102-1107.
  • 3Price A J, Short A, Kellett C, et al. Ten-year in vivo wear measurement of a fully congruent mobile bearing unicompartmental knee arthroplasty[J]. J Bone Joint Surg Br, 2005,87 ( 11 ) : 1493-1497.
  • 4Morgan H, Battista V, Leopold SS. Constraint in primary total knee arthroplasty[ J]. J Am Acad Orthop Surg, 2005,13(8 ) :515-524.
  • 5Marx R,Qunaibi M,Wirtz DC, et al.Surface pretreatment for prolonged survival of cemented tibial prosthesis components: full-vs, surface-cernentation technique[J]. Biomed Eng Online,2005, (4) :61.
  • 6Rader CP,Sterner T,Jakob F, et al .Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles[J] .J Arthroplasty, 1999,14(7) :840-848.
  • 7Warashina H, Sakano S, Kitamura S, et al. Biological reaction toalumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria[ J]. Biomaterials, 2003,24(21) :3655-3661.
  • 8Minoda Y, Kobayashi A, Iwaki H, et al. Polyethylene wear particle generation in vivo in an alumina medial pivot total knee prosthesis[J]. Biomaterials, 2005,26(30) :6034-6040.
  • 9Ingham E, Fisher J. Biological reactions to wear debris in total joint replacement[J] .Proc Inst Mesh Eng[H] ,2000,214(1):21-37.
  • 10Childs LM,Goater JJ,O'Keefe RJ,et al.Effect of anti-tumor necrosis factor-α gene therapy on wear debris-induced osteolysis[J].J Bone Joint Surg Am.2001,83-A(12):1789-1797.

共引文献5

同被引文献19

  • 1徐炜,董启榕.钛合金颗粒对成骨细胞骨保护素基因表达的影响[J].中华创伤骨科杂志,2006,8(6):562-565. 被引量：4
  • 2Savarino L,Granchi D,Ciapetti G,et al.Ion release in sta-ble hip arthroplasties using metal-on-metal articulating sur-faces:a comparison between short-and medium-term results[J].J Biomed Mater Res A,2003,66(3):450-456.
  • 3Boyce BF,Xing L.Functions of RANKL/RANK/OPG inbone modeling and remodeling[J].Arch Biochem Biophys,2008,473(2):139-146.
  • 4Tanaka S.Signaling axis in osteoclast biology and therapeutictargeting in the RANKL/RANK/OPG system[J].Am JNephrol,2007,27(5):466-478.
  • 5Theoleyre S,Wittrant Y,Tat SK,et al.The molecular tri-ad OPG/RANK/RANKL:involvement in the orchestrationof pathophysiological bone remodeling[J].Cytokine GrowthFactor Rev,2004,15(6):457-475.
  • 6Xu J,Kauther MD,Hartl J,et al.Study was performed atthe University of Duisburg-Essen,Germany[J].Effects ofalpha-calcitonin gene-related peptide on osteoprotegerin andreceptor activator of nuclear factor-κB ligand expression inMG-63osteoblast-like cells exposed to polyethylene particles[J].J Orthop Surg Res,2010,5:83.
  • 7Pioletti DP,Kottelat A.The influence of wear particles inthe expression of osteoclastogenesis factors by osteoblasts[J].Biomaterials,2004,25(27):5803-5808.
  • 8Drees P,Eckardt A,Gay RE,et al.Mechanisms of dis-ease:Molecular insights into aseptic loosening of orthopedicimplants[J].Nat Clin Pract Rheumatol,2007,3(3):165-171.
  • 9Sundfeldt M,Carlsson LV,Johansson CB,et al.Asepticloosening,not only aquestion of wear:a review of differenttheories[J].Acta Orthop,2006,77(2):177-197.
  • 10Jurado S,Garcia-Giralt N,Díez-Pérez A,et al.Effect ofIL-1beta,PGE(2),and TGF-beta1on the expression ofOPG and RANKL in normal and osteoporotic primary hu-man osteoblasts[J].J Cell Biochem,2010,110(2):304-310.

引证文献1

医学综述
2008年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部